Navigation Links
Aware Announces Appointment of New Directors
Date:2/16/2011

BEDFORD, Mass., Jan. 10, 2011 /PRNewswire/ -- Aware, Inc. (Nasdaq: AWRE), a leading technology innovator and software supplier to the telecommunications and biometrics industries, today announced that on January 5, 2011 its Board of Directors had appointed John S. Stafford, Jr. and John S. Stafford, III to the Aware Board of Directors.  

Mr. Stafford, Jr. was appointed a Class III Director and will serve on the Board's Nominating and Corporate Governance Committee.  Mr. Stafford, Jr. had previously been a director of Aware from 1988 to 1998.  

Mr. Stafford, III was appointed a Class II Director and will serve on the Board's Compensation Committee.  

Earlier today Aware filed a Form 8-K with the Securities and Exchange Commission announcing the appointments of Mr. Stafford, Jr. and Mr. Stafford, III to its Board of Directors.

On September 24, 2010, Aware announced that it was considering a spin-off of its patent licensing operations.  Aware is currently reviewing strategic options with respect to its patent licensing operations, including a potential spin-off.

About Aware

Aware is a leading technology and supplier for the telecommunications and biometrics industries. Aware has pioneered innovations at telecommunications standards-setting organizations for DSL and networking. Telecom equipment vendors and phone companies use Aware's DSL test and diagnostics modules and Dr. DSL® software to provision and troubleshoot DSL circuits globally. Aware is also a veteran of the biometrics industry, providing biometric and imaging software components used in government systems worldwide since 1992. Aware's interoperable, standard-compliant, field-proven imaging products are used in a number of applications, from border management to criminal justice to medical imaging. Aware is a publicly held company (Nasdaq: '/>"/>

SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Aware, Inc. Announces Q4 and FY2010 Earnings Conference Call
2. Aware, Inc. Announces Q4 and FY2010 Earnings Conference Call
3. Aware Announces Appointment of New Directors
4. New study calls for greater awareness of food supply for children with diabetes
5. Freshwater mussels discovered in urban Delaware river
6. Aware, Inc. Reports Third Quarter 2010 Financial Results
7. Aware, Inc. Announces Q310 Earnings Conference Call
8. Aware to Introduce Several New Software Products at the Biometrics Consortium Conference
9. Aware, Inc. Reports Second Quarter 2010 Financial Results
10. Aware Biometrics Software Provided for Large Federal Agencys PIV Credentialing System
11. Awares Biometric Services Platform (BioSP) Deployed By a Large European Police Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... in the West African nation Burkina Faso today ... Sayana Press has the potential to increase access ... system and in communities by combining a lower-dose ... medroxyprogesterone acetate)with the BD Uniject injection system. , ... countries expected to begin introducing Sayana Press in ...
(Date:7/9/2014)... healthy women differ from bacteria in women with ... from Loyola University Chicago Stritch School of Medicine. ... in the American Society for Microbiology,s online journal ... play a role in female urinary health. , ... poorly understood, condition with symptoms similar to urinary ...
(Date:7/9/2014)... Cancer Research Centre (CNIO) have discovered that NANOG, an ... division in stratified epitheliathose that form part of the ... the vaginain adult organisms. According to the conclusions of ... , this factor could also play a role in ... the oesophagus and skin. , The pluripotency factor NANOG ...
Breaking Biology News(10 mins):Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3CNIO scientists discover that pluripotency factor NANOG is also active in adult organisms 2
... the limits of life in extreme environments, scientists have discovered ... an Antarctic lake sealed under more than 65 feet of ... the Proceedings of the National Academy of Sciences , ... been isolated from the surface environment -- and external sources ...
... Johns Hopkins researchers report concrete steps in the use of ... drugs. Their success highlights a pathway toward faster, cheaper drug ... to pre-test a therapy,s safety and effectiveness on cultured clones ... in an article published November 25 on the website of ...
... the first time that marine algae can be just as ... scientists genetically engineered marine algae to produce five different kinds ... used could be employed to enhance the yield of petroleum-like ... in a paper published online in the current issue of ...
Cached Biology News:UIC scientists find ancient microbes in salty, ice-sealed Antarctic lake 2Study advances use of stem cells in personalized medicine 2Bioengineered marine algae expands environments where biofuels can be produced 2
(Date:1/15/2014)... device," Nobel laureate Herbert Kroemer famously observed, referring ... the junctures where layers of different materials meet. ... between layers of metal oxides are becoming increasingly ... spintronics, high-temperature superconductors, ferroelectrics and multiferroics. Realizing the ...
(Date:1/15/2014)... 15, 2014 Look inside the new ... for the lab, from fluid handling to instruments to ... ship when you order. , Preferred Solutions features ... from the L/S® model for precise flow control and ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... PAREXEL International Corporation (Nasdaq: PRXL ) will ... January 31, 2011 after the close of the stock market. ... www.PAREXEL.com and on the PR Newswire website at ... and live webcast at 10:00 a.m. EST on Tuesday, February ...
... 2011 Advanced Pain Remedies (APR), a subsidiary of ... has been received, to advance its lead development candidate, ... targeting of specific cell types to manipulate them for ... million grant from the National Cancer Institute (NCI). Advanced ...
... CITY, Kan., Jan. 7, 2011 Aratana Therapeutics, a newly-formed ... animal health industry, today announced that it has closed a ... Avalon Ventures. "At Aratana, we will be focused ... them in new ways to treat and care for animals," ...
Cached Biology Technology:PAREXEL Announces Date of Second Quarter Fiscal Year 2011 Earnings Release and Conference Call 2Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP 2Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP 3